Ahmed ClearPath® and Ahmed ClearPath ST

Ahmed ClearPath^® and Ahmed ClearPath ST

INTENDED USE: The Ahmed ClearPath® glaucoma drainage devices are indicated for the management of refractory glaucoma where previous surgical treatment has failed or is not expected to provide satisfactory results.

PATIENT POPULATION: ADULT

PROJECT NAME: Cortez

DEVELOPMENT TEAM:

Ahmed ClearPath: John Koontz, Joey Tran (Project and Technical Lead), Ramon Venegas Jr (Independent Reviewer), Patrick Chen, Wyatt Deane, Daniel Martell

Ahmed ClearPath ST: Chris Kee (Project Lead), Cameron Kennedy (Co-Project Lead), Cody Jackson (Tech Lead), Jason Mohr, Harold Miller (Independent Reviewer), Helena Gan, Joey Tran

PRODUCT SUPPORT:

EXECUTIVE TEAM: Bilal Khan, Khalid Mansour, Rafael Chan, John Koontz, Cristina Avalos, Brandon Blanche, Oswaldo Pompa

COMMERCIAL TEAM: Rafael Chan, Annamarie Piccioni, Malika Singh, Ray Nix, Yasir Iqbal, Toya Ashley, Jackie Martinez-Cearley (ACP ST)

QUALITY AND REGULATORY TEAM: Cristina Avalos, Daniel Martell, Ramon Venegas, Lorena Diaz, Erick Nunez, Matt Emperado, Michael Waldon, Mukesh Sabarad

SUSTAINING AND PRODUCTION TEAM: Brandon Blanche, Oswaldo Pompa, Jonathan Menendez, Pete Albano, Erik Lazo (ACP ST)

CLINICAL AFFAIRS TEAM: Dr Malik Kahook (CMA)

LEGAL TEAM: David Klann

PRODUCT DEVELOPMENT DURATION:

43 MONTHS (03/2017 – 10/2020) (ACP)
6 MONTHS (09/2023 – 03/2024) (ACP ST)

REGULATORY CLEARANCE RECEIVED: FDA 510(k) K182518 JANUARY 18, 2019

SURGEON / PATIENT TESTIMONIALS:

“Ahmed ClearPath® has been a welcomed addition to the surgical glaucoma treatment options for my patients. I've been particularly happy with the use of the Ahmed ClearPath® 250 because it offers a reservoir plate with a large surface area while eliminating the need to implant the device underneath the rectus muscles. Some of the earlier challenges I experienced with ligation of the tube for the early-flow restriction have been completely resolved by adding a single-loop just prior to the triple-loop throw of the ligation suture. It has become my go-to, non-valved glaucoma drainage implant.”
Peter ChangBaylor Medical College, Houston, Texas

“The Features of the Ahmed ClearPath® offer efficiency and advantages in my surgical routine for non-valved tube patients. The flexibility of the plate and anterior location of the suture eyelets makes for easier manipulation and implantation. Having performed non-valved tubes with and without a ripcord, I find it helpful to use the included 4-0 polypropylene ripcord suture along with a dissolvable ligating vicryl suture around the tube to help control flow and reduce risk of hypotony in the immediate post operative period for my patients/”
Devang BhoiwalaThe Eye Center of New Jersey, Bloomfield, New Jersey

“The Ahmed ClearPath® allows for a small incision technique with its malleable silicone material that naturally unfolds with a curvature that sits flush against the sclera. Also, the anteriorly positioned eyelets are beneficial for easier access and in my opinion one of the best features of this device.”
Paul SinghThe Eye Centers of Racine & Kenosha, Kenosha, Wisconsin